| Feb 1, 2021 |
|
DW Healthcare Partners Invests in Parnell |
| Jan 29, 2021 |
|
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd |
| Jan 22, 2021 |
|
Parnell Announces Notice of 2020 Annual General Meeting and Explanatory Memorandum |
| Jan 21, 2021 |
|
DWHP Announces Extension of The Expiration Time of Its Tender Offer |
| Dec 21, 2020 |
|
DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd |
| Dec 21, 2020 |
|
Results of Annual General Meeting of Shareholders Held December 17, 2020 |
| Dec 23, 2019 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Update |
| Oct 14, 2019 |
|
Parnell Pharmaceuticals Holdings Ltd Announces New CDMO Agreement and Business Update |
| Jun 7, 2019 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Quarter Ended 31 March 2019 |
| Apr 30, 2019 |
|
Notice of Annual General Meeting and Explanatory Memorandum |
| Apr 5, 2019 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Year Ended 31 December 2018 and 2019 Guidance |
| Nov 2, 2018 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018 |
| Aug 3, 2018 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018 |
| Jul 31, 2018 |
|
Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management |
| Jun 5, 2018 |
|
Results of Annual General Meeting of Shareholders Held May 31, 2018 |
| Apr 30, 2018 |
|
Notice of Annual General Meeting and Explanatory Memorandum |
| Apr 27, 2018 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended March 31, 2018 and Reports 2017 Full Year Financial Results |
| Feb 22, 2018 |
|
Results of General Meeting of Shareholders Held February 22, 2018 |
| Jan 11, 2018 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Nine Months Ended September 30, 2017; Board and Senior Management Changes; Strategic Review of Development Pipeline Including Zydax Canine and 2018 Guidance |
| Jan 11, 2018 |
|
Notice of General Meeting and Explanatory Memorandum |
| Jan 4, 2018 |
|
Parnell Appoints Tony G Hartnell AM to Board of Directors |
| Jan 3, 2018 |
|
Results of General Meeting of Shareholders held December 29, 2017 |
| Nov 21, 2017 |
|
Notice of Annual General Meeting and Explanatory Memorandum |
| Aug 17, 2017 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017 |
| May 24, 2017 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Business Results Update |
| May 18, 2017 |
|
Parnell to Report Business Update for the Three Months Ended March 31, 2017 on May 24, 2017 |
| Apr 28, 2017 |
|
Notice of Annual General Meeting and Explanatory Memorandum |
| Mar 21, 2017 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2016 |
| Feb 27, 2017 |
|
UPDATED: Parnell to Report Financial Results for Fiscal Year 2016 on March 21, 2017 |
| Feb 23, 2017 |
|
Parnell to Report Financial Results for Fiscal Year 2016 on March 22, 2017 |
| Dec 19, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ |
| Dec 9, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the OTC Pink® Open Market |
| Dec 9, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the OTC Pink® Open Market |
| Nov 22, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility |
| Nov 2, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016 |
| Oct 27, 2016 |
|
Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016 |
| Aug 4, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016 |
| Jul 26, 2016 |
|
Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016 |
| Jul 26, 2016 |
|
Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016 |
| May 31, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial |
| May 12, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock |
| Apr 22, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update |
| Apr 18, 2016 |
|
Parnell to Report Business Results for the Three Months Ended March 31, 2016 on April 22, 2016 |
| Mar 31, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies Animal Health Summit |
| Feb 24, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2015 |
| Feb 18, 2016 |
|
Parnell to Report Financial Results for Fiscal Year 2015 on February 24, 2016 |
| Jan 20, 2016 |
|
UPDATE — Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Capital Fund to Purchase Ordinary Shares |
| Jan 19, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Captial Fund to Purchase Ordinary Shares |
| Jan 11, 2016 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference in San Francisco |
| Dec 17, 2015 |
|
Parnell Appoints Ellen B. Richstone and Dr. David K. Rosen to the Board of Directors |
| Dec 17, 2015 |
|
Parnell Appoints Ellen B. Richstone and Dr. David K. Rosen to the Board of Directors |
| Nov 18, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Global Healthcare Conference in London |
| Oct 21, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Third Quarter Business Results |
| Oct 9, 2015 |
|
Parnell to Report Financial Results for the Nine Months Ended September 30, 2015 on October 21, 2015 |
| Oct 9, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Restructures Board |
| Sep 28, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Ladenburg Thalmann 2015 Healthcare Conference |
| Aug 11, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2015 |
| Aug 10, 2015 |
|
Parnell Appoints Peter A. Croden to Board of Directors |
| Jul 29, 2015 |
|
Parnell to Report Financial Results for the Six Months Ended June 30, 2015 on August 11, 2015 |
| Jun 18, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Investor Day Highlights |
| Jun 18, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces $11 Million Secured Term Loan Facility |
| Jun 18, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Positive Top-Line Pivotal Trial Results for Zydax(R), Disease-Modifying Osteoarthritis Drug in Dogs |
| Jun 8, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Participate in Two Upcoming Investor Conferences |
| May 20, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Healthcare Conference |
| Apr 22, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Results |
| Apr 13, 2015 |
|
Parnell to Discuss First Quarter Business Performance on April 22, 2015 |
| Mar 9, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Animal Health Summit |
| Feb 25, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended December 31, 2014 |
| Jan 12, 2015 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference |
| Dec 19, 2014 |
|
Parnell Management Adopts 10b5-1 Trading Plans |
| Dec 9, 2014 |
|
Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility |
| Dec 9, 2014 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Change in Fiscal Year-End |
| Nov 12, 2014 |
|
Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences |
| Sep 15, 2014 |
|
Parnell Pharmaceuticals Holdings Ltd Announces Fiscal Year 2014 Financial Results |
| Sep 10, 2014 |
|
Parnell to Report Fiscal Year 2014 Financial Results September 15, 2014 |
| Sep 8, 2014 |
|
Parnell Appoints US-Based Independent Directors Phyllis Gardner, M.D., and David L. Greenwood to Its Board of Directors |
| Sep 3, 2014 |
|
Parnell Announces Results From the Successful Efficacy Study for Zydax(R) |
| Jul 24, 2014 |
|
Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration |
| Jun 18, 2014 |
|
Parnell Pharmaceuticals (NASDAQ: PARN) to Ring The NASDAQ Stock Market Opening Bell in Celebration of IPO |
| May 21, 2014 |
|
Parnell Pharmaceuticals Files Registration for Proposed Initial Public Offering |
| Feb 25, 2013 |
|
Parnell Launches Synchronization Pack™ |
| Aug 1, 2009 |
|
Australian Veterinary Pharmaceuticals Company Opens World Class Manufacturing Facility |